USPTO serial 79154691
BTG
Reviewed by CopyMark Law Group
Reg. 4848446Status 404
- Filing date
- Status date
- Registration date
- Nov 10, 2015
- Examiner
- JACKSON, ELIZABETH FLEMING
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BTG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan Hyman
Jonathan Hyman Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Computer firmware for controlling medical devices; ] computer firmware for controlling and managing patient medical information; [ computer hardware; computer peripherals; computer software for use in medical devices, namely, software for the operation of medical devices and for analyzing the results of testing completed through medical devices; computer software for use in ultrasound devices, namely, software for the operation of ultrasound devices and for analyzing ultrasound images; ] computer software for medical monitoring, medical testing and patient evaluating programs; computer software for the diagnosis, treatment, and management of health conditions and illnesses; [ computer software for the diagnosis, assessment, treatment, management, and aftercare of conditions in the fields of sclerotherapy, phlebology, angiology, proctology and interventional oncology and emphysema; computer software for the diagnosis, assessment, treatment, management, and aftercare of tumors; computer software for the diagnosis, assessment, treatment, management, and aftercare of varicose veins, arterio-venous malformations, oesophageal varices, and hydroceles; computer software for the diagnosis, assessment, treatment, management and aftercare of emphysema; ] computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, [ health care facilities management, materials management, ] resources utilization; [ , billing and accounting, and the review of health care facilities, services and clinical records;] computer software for use by health care providers to analyze the outcomes of medical procedures and information relating to patient care; [ computer software for use in database management; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable electronic publications in the nature of questionnaires on the subject of healthcare, medicine, medical treatment and patient care; ] downloadable electronic publications in the nature of patient reported outcome questionnaires on the subject of healthcare, medicine, medical treatment and patient care for use with a telecommunications device; downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, and media players that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for use in monitoring and diagnosing biochemical reactions and phenomena; [ computer software for use in database management, namely, computer databases for clinical use, clinical governance, clinical audit, collecting and analysing information relating to patient demographics, procedures and outcomes; downloadable electronic questionnaires on the subject of healthcare, medicine, medical treatment and patient care; downloadable electronic patient reported outcome questionnaires; downloadable electronic patient reported outcome questionnaires for use with a telecommunications device; ] downloadable publications in electronic form, namely, [ journals, magazines, periodicals, ] articles [ and books ] in the fields of healthcare, the use of pharmaceuticals [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, patient care, [ medical diseases, disorders ] and related treatments; downloadable electronic publications, namely, [ journals, magazines, periodicals, ] articles [ and books ] provided on-line from databases or the internet in the fields of healthcare, the use of pharmaceuticals [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, patient care, [ medical diseases, disorders ] and related treatments; [ electrically operated diagnostic testing apparatus and instruments, namely, electrically operated diagnostic testing apparatus and instruments for use in the fields of sclerotheraphy, phlebology, angiology proctology, interventional oncology, tumors, basal cell carcinoma, emphysema, varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and skin complaints including psoriasis and eczema for laboratory or research use * ; ] all of the aforesaid goods being for use in relation to pharmaceutical, veterinary, [ surgical, ] medical, medical diagnostic, biotechnology, drug discovery or healthcare goods or services * | SECTION 70 - CANCELLED | — |
| 016 | Printed matter and printed publications, namely, books, manuals, brochures and other literature in the nature of pamphlets, [ printed periodicals, ] course materials in the nature of educational books, [ flash cards and ] worksheets, guide books, and user manuals and leaflets in the fields of healthcare, the use of pharmaceuticals, [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, patient care, [ medical diseases, disorders ] and related treatments; printed journals, [ printed periodicals, ] printed reports [ and printed questionnaires ] in the field of healthcare, pharmaceutical products, healthcare [ and medical diseases, disorders ] and related treatments, medicine, medical treatment and related hotline services, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare guidelines [ ; wallet cards in the nature of note cards that fold to fit neatly in a wallet and documents in the nature of hand-outs and paper identification cards all featuring personal and medical information concerning an individual's health condition; wallet cards in the nature of note cards that fold to fit neatly in a wallet and documents in the nature of hand-outs and paper identification cards all featuring contact information for a medical information hotline ] | SECTION 70 - CANCELLED | — |
| 035 | [ Business management; business administration; office functions; business administration services, namely, the registration, transcription and compilation of health, medical and personal information into computer databases; business administration services database management, namely, collection, storage, management and retrieval of health, medical and personal information; membership services, namely, providing discounts and processing rebates in the field of healthcare and providing information in the field of discounts and rebates in the field of healthcare * Business management; business administration; office functions; * business administration services, namely, * the registration, transcription and compilation of health, medical and personal information into computer databases; database management, namely, collection, storage, management and retrieval of health, medical and personal information; ] membership services, namely, [ providing discounts and processing rebates in the field of healthcare and ] providing information in the field of [ discounts and ] rebates in the field of healthcare | SECTION 70 - CANCELLED | — |
| 036 | [ Insurance services, namely, claims administration, medical insurance claims processing, insurance tracking services, namely, providing information and on-line computer databases for the purpose of review and verification of Medicaid eligibility status and related information, medical insurance claims administration and medical insurance claims processing; Claims administration services in the field of health insurance, namely, claims tracking assistance services; Insurance claims processing, namely, processing of medical insurance and pharmaceutical claims and reimbursement payment processing in the field of medical insurance and pharmaceutical claims; Healthcare navigation services, namely, health insurance policy review services; health insurance claims negotiation and appeal services; providing educational information in the field of health insurance; providing counselling and consulting in the field of healthcare benefits ] | SECTION 71 - CANCELLED | — |
| 041 | Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, [ medical diseases, disorders ] and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, [ radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus ] and consultation relating thereto; educational services, namely, conducting [ live and ] online seminars, [ classes, workshops, conferences, ] lectures, panel [ discussions, ] and training programs in the fields of healthcare, the use of pharmaceutical, [ and medical devices, ] medical research, [ surgery,] medical science, medicine [ and medical diseases, disorders ] and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals [ and medical devices ] , medical research, [ surgery, ] medical science, medicine, [ medical diseases, disorders ] and related treatments; educational services, namely, conducting [ live and ] online seminars, [ classes, workshops, conferences, ] lectures, [ panel discussions ] and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online [ and telephonic ] instruction and courses in the fields of health and medical issues | SECTION 70 - CANCELLED | — |
| 042 | [ * Electronic * Storage of health and/or medical and/or personal information * ; all of the aforesaid services being for use in relation to pharmaceutical, veterinary, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare goods or services * ] | SECTION 71 - CANCELLED | — |
| 044 | [ Medical services; medical services relating to ultrasound waves to enhance drug delivery and medically activate drugs; medical services in the nature of dissolution of thrombotic blood clot material using catheters; ] providing * a website featuring * medical information regarding medicine, medical treatment, patient care, pharmaceuticals, prescription drugs, [ medical devices, ] ordering, prescribing, and dispensing practices of drugs, treatment and aftercare [ via a website; medical and veterinary services, namely, diagnosis, assessment, treatment and aftercare in the fields of sclerotherapy, phlebology, angiology, proctology, interventional oncology, ablation of tumours using embolic beads, ablation of tumours using embolic radioactive beads, ablation of tumours using embolic drug eluting beads and emphysema, and in connection with varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical analysis for the diagnosis and treatment of cancer, tumors, emphysema, sclerotherapy, phlebology, angiology, proctology, varicose veins, arterio-venous malformations, oesophageal varices, sterilisation treatment, circulatory system conditions, and pulmonary and thoracic conditions; pharmacy advice in the nature of pharmaceutical and medical device advice; medical services for diagnosis in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical health assessment services, namely, medical diagnosis of diseases and conditions in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical treatment of diseases and conditions in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical after care services in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; ]advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment [ and services; ] medical advisory services relating to patient care; [ conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and ] providing health advice and information services; [ conducting health assessment surveys, health risk assessment surveys, and treatment outcome surveys, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information and health advice and information services; ] healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; [ healthcare consultancy services, namely, providing a hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by hotline services; providing health and medical information by hotline services; ] advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; [ medical equipment rental; ] advisory services relating to medical apparatus, instruments and preparations; advisory services relating to medical services; providing medical advisory, consultancy and information services relating to the aforesaid services [ ; medical services relating to treatment of snakebite envenomation, digoxin or digitalis toxicity, methotrexate toxicity, fluorouracil toxicity and chemotherapy toxicity ] | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BTG International Limited
- Other trademarks owned by Protherics Medicines Development Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by Protherics Medicines Development Limited
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BTG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 18, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 18, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 9, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 9, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jun 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 25, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 25, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 25, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 24, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 17, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 30, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 31, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 30, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Aug 30, 2023 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 24, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 6, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 2, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 10, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 3, 2018 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 1, 2018 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 31, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Aug 31, 2018 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 24, 2017 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 17, 2017 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 17, 2017 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 17, 2017 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 23, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 8, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 2, 2016 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 2, 2016 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 19, 2016 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| May 19, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 19, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 6, 2016 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Apr 6, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 10, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 21, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 4, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 12, 2015 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 12, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Nov 12, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 10, 2015 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Nov 10, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 30, 2015 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 30, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 25, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 25, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 5, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 5, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 5, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 17, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 15, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 1, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 30, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 30, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 30, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 25, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2015 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 27, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 12, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 24, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 24, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 20, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 13, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |